Skip to main content
. 2022 Aug 21;92(11):1027–1039. doi: 10.1111/josh.13243

Table 1.

Characteristics of Students, School‐Provided Supports, and Community Characteristics of Survey Respondents Ages 13‐19 Attending K‐12 Schools by Learning Modality (In‐Person, Hybrid, or Remote/Virtual) for the SY 2020‐2021

Student Learning Modality, N, % (95% CI)
Overall, N, % (95% CI) In‐person Hybrid Remote/Virtual p‐Value
Total 2152 425 (19.8%) 884 (41.1%) 843 (39.2%)
Academic grade change* <.001
Declined 632 29.8 (27.8, 31.9) 83 19.9 (16.2, 24.3) 267 30.1 (27.1, 33.4) 282 34.4 (31.1, 37.9)
Same/improved 1496 70.2 (68.1, 72.2) 338 80.1 (75.7, 83.8) 608 69.9 (66.6, 72.9) 550 65.6 (62.1, 68.9)
Student sociodemographic characteristics
Gender .02
Female 1071 49.0 (46.7, 51.2) 205 46.2 (41.3, 51.2) 412 46.6 (43.2, 50.0) 454 52.8 (49.2, 56.3)
Male 1081 51.0 (48.8, 53.3) 220 53.8 (48.8, 58.7) 472 53.4 (50.0, 56.8) 389 47.2 (43.7, 50.8)
Race/ethnicity <.001
Non‐Hispanic white 1117 52.8 (50.6, 55.0) 264 62.7 (57.8, 67.4) 527 61.3 (57.9, 64.6) 326 39.1 (35.7, 42.6)
Non‐Hispanic black 272 13.0 (11.6, 14.6) 44 11.4 (8.5, 15.2) 87 9.6 (7.8, 11.9) 141 17.2 (14.7, 20.1)
Hispanic 530 25.6 (23.7, 27.6) 83 19.9 (16.1, 24.2) 187 21.3 (18.6, 24.3) 260 32.9 (29.6, 36.3)
Non‐Hispanic other 233 8.6 (7.6, 9.8) 34 6.0 (4.2, 8.4) 83 7.7 (6.2, 9.6) 116 10.8 (9.0, 13.0)
School level .6
High school (grades 9‐12) 1367 67.7 (65.6, 69.6) 261 65.7 (60.9, 70.1) 559 67.7 (64.5, 70.7) 547 68.6 (65.4, 71.7)
Middle school (grades 6‐8) 785 32.3 (30.4, 34.4) 164 34.4 (29.9, 39.1) 325 32.3 (29.3, 35.5) 296 31.4 (28.3, 34.6)
Student health/behavioral characteristics
Mental health
Has anxiety symptoms 478 22.3 (20.5, 24.2) 88 20.8 (17.0, 25.1) 215 24.1 (21.3, 27.2) 175 21.2 (18.4, 24.3)   .3
Has depression symptoms 422 19.5 (17.8, 21.3) 78 18.8 (15.1, 23.0) 174 19.0 (16.5, 21.9) 170 20.4 (17.7, 23.4)   .7
Substance use since pandemic began § 348 15.9 (14.3, 17.6) 79 19.2 (15.5, 23.5) 152 16.5 (14.2, 19.3) 117 13.5 (11.3, 16.1)   .04
School‐provided supports
Received education‐related services 1515 70.1 (68.0, 72.1) 285 66.1 (61.2, 70.7) 633 71.9 (68.7, 74.8) 597 70.3 (67.0, 73.5)   .1
Received health‐related services 288 13.1 (11.7, 14.7) 75 17.1 (13.7, 21.2) 111 12.8 (10.7, 15.4) 102 11.5 (9.4, 13.9)   .02
Community characteristics
US Census region # <.001
Midwest 411 20.8 (19.0, 22.8) 96 25.0 (20.9, 29.7) 198 25.2 (22.2, 28.4) 117 14.3 (12.0, 17.0)
Northeast 385 16.5 (15.0, 18.1) 46 9.5 (7.1, 12.7) 190 19.9 (17.3, 22.6) 149 16.6 (14.2, 19.3)
South 873 38.6 (36.4, 40.7) 230 51.4 (46.4, 56.4) 314 33.2 (30.0, 36.4) 329 37.7 (34.3, 41.1)
West 483 24.1 (22.2, 26.1) 53 14.0 (10.7, 18.1) 182 21.9 (19.1, 24.9) 248 31.5 (28.2, 34.9)
Locality** <.001
Rural 425 14.1 (12.8, 15.4) 106 18.5 (15.3, 22.3) 199 16.3 (14.2, 18.7) 120 9.5 (7.9, 11.4)
Suburban 1085 56.4 (54.2, 58.5) 220 58.5 (53.6, 63.2) 433 55.7 (52.2, 59.0) 432 56.0 (52.5, 59.4)
Urban 642 29.6 (27.6, 31.7) 99 23.0 (19.1, 27.4) 252 28.1 (25.1, 31.2) 291 34.5 (31.3, 37.9)
Social vulnerability index †† , ‡‡ <0.001
Low 750 35.7 (33.6, 37.9) 163 39.8 (35.0, 44.8) 331 38.9 (35.5, 42.3) 256 30.5 (27.3, 33.9)
Moderate 687 31.6 (29.6, 33.7) 138 33.2 (28.7, 38.1) 290 32.0 (28.9, 35.3) 259 30.5 (27.4, 33.9)
High 715 32.6 (30.6, 34.7) 124 27.0 (22.9, 31.6) 263 29.1 (26.1, 32.4) 328 39.0 (35.6, 42.5)
High days of SARS‐CoV‐2 transmission ‡‡ , §§ .05
0 days 1249 62.0 (59.8, 64.2) 254 64.0 (59.0, 68.7) 494 59.2 (55.6, 62.6) 501 64.0 (60.5, 67.4)
1‐7 days 472 22.3 (20.5, 24.3) 85 19.7 (16.0, 24.0) 200 22.9 (20.1, 26.0) 187 23.1 (20.1, 26.2)
8‐14 days 315 15.7 (14.1, 17.4) 187 16.4 (13.0, 20.5) 145 17.9 (15.3, 20.9) 102 12.9 (10.7, 15.6)

Table shows unweighted counts (N), weighted overall and column percentages (%), and weighted 95% confidence intervals (CIs). p‐Value represents associations between the groups of learning modalities by each variable of interest. p‐Values <.05 were considered statistically significant.

SY, school year.

*

Represents change in letter grades since before the start of the COVID‐19 pandemic (before February 2020). Grade change could not be computed for n = 24 survey respondents because they reported “none of these grades” or “not sure” for one or both questions about academic grades.

Non‐Hispanic other race/ethnicity category includes Asian, American Indian or Alaska Native, Native Hawaiian or Pacific Islander, some other race, or selected more than one race category. The Non‐Hispanic other category is not disaggregated due to small cell size generating unstable estimates and to protect confidentiality.

Using the GAD‐2 scale (Generalized Anxiety Disorder), respondents with anxiety symptoms represent those who scored ≥3 for anxiety, indicating a need for follow‐up screening for anxiety. Using the PHQ‐2 scale (Patient Health Questionnaire), respondents with depression symptoms represent those who scored ≥3 for depression, indicating a need for follow‐up screening for depression.

§

Started or increased use of at least 1 substance (alcohol, tobacco, prescription drug, or non‐prescription drug) to help cope with stress or emotions, taken in a way not recommended by a doctor.

Education‐related services received during SY 2020‐2021 (tutoring, accommodations for assignments, academic support, and/or individual classroom support).

Health‐related services received during SY 2020‐2021 (occupational therapy, speech therapy, and/or behavioral/mental health support).

#

Based on survey respondent's self‐reported state of residence.

**

Based on survey respondent's self‐reported location of school. This information was missing for n = 188 respondents.

††

2018 CDC/ATSDR Social Vulnerability Index (SVI) for the county where respondent school is located. Low = counties in bottom one‐third, or tertile, of SVI scores (lowest vulnerability). Moderate = counties in middle tertile of SVI scores. High = counties in top tertile of SVI scores (highest vulnerability).

‡‡

Could not be computed for n = 188 survey respondents due to missing school location.

§§

Number of days that the county where the school is located was designated as having a high SARS‐CoV‐2 transmission level (8‐14 days).